Complexa
Complexa is a clinical-stage platform biopharmaceutical company researching and developing endogenous human cell signaling technologies targeting an array of prevalent inflammatory, fibrotic, and CNS diseases. The company's proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/function-related mediators that are designed to treat various diseases. NFAs are cell-signaling agents that regulate major inflammatory signaling pathways (e.g., Nrf2, NFkB, and HSF). Capitalizing on their identification and synthesis of these endogenous signaling mediators, Complexa's technologies act to amplify the existing anti-inflammatory and metabolic signaling mechanisms that promote the resolution and repair of acute and chronic tissue injury and disease. It is headquartered in Berwyn, Pennsylvania.
Domain
complexarx.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$62.0M
Founded
2007
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does Complexa use?+
Complexa uses 8 technologies including Radix UI, Alibaba Cloud CDN, Cloudflare.
What industry is Complexa in?+
Complexa operates in the Biotechnology industry.
Where is Complexa based?+
Complexa is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026